Despite Regulatory Slowdown, Compliance Costs Continue to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Despite Regulatory Slowdown, Compliance Costs Continue to Rise

NEW HAVEN, Conn., July 16, 2014 (GLOBE NEWSWIRE) -- While the pace of regulatory change slowed in the second quarter of 2014, community financial institutions' compliance-related costs and staffing needs continued to increase, according to the latest Banking Compliance Index SM (BCI).

The index, compiled and analyzed by experts at Continuity Control ™ , a New Haven, Conn.-based provider of compliance management systems, found that community banks needed to spend an additional $34,755 on compliance costs in the second quarter of 2014. That's almost the same amount ($39,772) that they were required to spend during the more volatile second quarter of 2013. The average institution also needed to devote an extra 517 hours to keeping up with new compliance requirements in the second quarter, which is equivalent to 1.48 full-time employees and a 7 percent increase compared to the first quarter of 2014.

A chart accompanying this release is available at http://media.globenewswire.com/cache/24805/file/27616.pdf

"When it comes to regulatory change, community banks are getting a chance to catch their breath, but it's not having as dramatic an effect on their costs and resources as they'd like it to," said Pam Perdue, executive vice president of regulatory insight at Continuity Control. "It's becoming clear that, whether the regulatory pace increases or decreases, compliance costs continue to rise thanks to more stringent enforcement and the specialized expertise required to manage compliance."

Staffing costs are partly responsible for the continued increase in compliance spending, as in-demand compliance specialists are able to command higher paychecks. The economic recovery has led to overall wage increases for other employees as well. This further hikes compliance spending because every staff member in a financial institution plays a role in ensuring compliance.

Recent enforcement actions have demonstrated that regulators are also continuing to crack down on institutions of all sizes, and enforcement actions can be costly and time-consuming. According to the BCI, 170 enforcement actions were issued in the second quarter. If the current rate of enforcement holds, 10 percent of all financial institutions will be dealing with the effects of enforcement actions during the next year. Regulators have even started issuing penalties to board members for failure to properly oversee their institutions' compliance issues.

"When it comes to compliance inaction, the frustration level for regulators is increasingly higher and the tolerance level is lower," Perdue said. "Financial institutions and their boards need to demonstrate that they have sound compliance management systems in place. Without them, good reputations and hard-won earnings can be lost to regulatory enforcement."

About the BCI

The BCI employs a data-driven approach to provide unique insights into the depth and breadth of regulatory compliance workload impact measured in terms of a Full-time Employee (FTE) Consumption Score.

The BCI is calculated each quarter using a multivariate analysis that can be weighted across different contexts and is calibrated to determine the regulatory impact on financial institutions of varying sizes, product mixes, and regulatory oversight. Using key indicators including volume, velocity and complexity of regulatory change; time expended to meet regulatory requirement(s); and supervision and the enforcement climate, the BCI's sophisticated metrics are unmatched in the industry.

The BCI tracks:

  • Regulatory Changes: A total count of applicable financial regulatory changes throughout the quarter.
  • Page Volume: The number of pages associated with each of the regulatory changes—indicative of the complexity and workload involved with reviewing and interpreting each change.
  • Enforcement Action Information (EA): Analysis of the public enforcement actions that have been issued during a quarter.

More than 800 financial institution professionals attended the Continuity Control RegAdvisor Quarterly Briefing webcast Thursday, July 10. During this session, regulatory experts reviewed the Q2 2014 BCI metrics and provided in-depth information on the quarter's regulatory changes, a workload assessment of these changes and the required actions to avoid penalties. A recording of this session is available at http://info.continuity.net/q2-2014-regadvisor-briefing .

About Continuity Control

Continuity Control is a Compliance Management System (CMS) that has been engineered to reduce the regulatory impact (time, cost and risk) for community banks and credit unions. This single, unified system automates the entire regulatory lifecycle; managing regulatory updates, policies, procedures, risk, vendors, audit, business continuity and exam preparation along with compliance strategy and planning. Built by bankers and former examiners, the CMS's advanced software has been coupled with expert personalized service to help financial institutions quickly adapt to regulatory change, streamline the workload and ensure compliance.

Sarah Eigner www.csg-pr.com 720-726-5454

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 637

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 202

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 345

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 60

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 203

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 215

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 107

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

Li Auto Inc. Reports Record Revenue and Milestone Deliveries

Updated Category News Views 89

Li Auto Inc. Announces Impressive Financial Results In the latest quarter, Li Auto Inc. reported a remarkable total revenue of RMB42.9 billion (approximately US$6.1 billion), showcasing a year-over-year growth of 23.6%. This impressive performance reflects the company's strong market presence and strategic execution. Quarterly Deliveries and Growth In terms of vehicle...

Continue Reading
LifeWallet's $2 Million Settlement and Strategic Progress Ahead

Updated Category News Views 162

LifeWallet's Recent Settlement Progress LifeWallet, formerly known as MSP Recovery, has recently made headlines by announcing a preliminary $2 million settlement as part of its portfolio of pharmaceutical litigation cases. This development is just one part of the company's broader strategy to engage various pharmaceutical and medical device manufacturers. The commitment...

Continue Reading
Revolutionary Approaches to Managing Resistant Hypertension

Updated Category News Views 261

Understanding Resistant Hypertension Resistant hypertension is a significant challenge for many patients, often referred to as the silent killer due to its insidious nature. Many individuals suffering from high blood pressure are unaware they have it, leading to severe health complications like cardiovascular disease over time. With the upcoming World Hypertension Day,...

Continue Reading
Understanding Wipro's Anticipated Earnings Performance

Updated Category News Views 51

Understanding Wipro's Anticipated Earnings Performance Wipro (WIT) is poised to release its latest quarterly earnings shortly. Investors are eager to gain insights from this upcoming report, which is shaping up to be a pivotal moment for the company. With analysts estimating an earnings per share (EPS) of $0.07, stakeholders are closely watching for news that could...

Continue Reading
Breakthrough Gene Therapy for Parkinson's Secures FDA Designation

Updated Category News Views 276

Significant FDA Recognition for AB-1005 AskBio Inc., known for its groundbreaking work in gene therapy, has made headlines with the announcement that its investigational gene therapy AB-1005 has received the esteemed Regenerative Medicine Advanced Therapy (RMAT) designation from the United States Food and Drug Administration (FDA). This acknowledgement comes on the heels...

Continue Reading